Center-Authored Papers

Filters: Author is Lindor, Noralane M  [Clear All Filters]
Journal Article
Dashti GS, Buchanan DD, Jayasekara H, Ouakrim DA, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S et al..  2016.  Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Lindor NM, Yang P, Evans I, Schowalter K, de Andrade M, Li J, Jeavons E, Peterson G, Gallinger S, Bapat B et al..  2010.  Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry.. Molecular genetics and metabolism. 99(2):157-9. Abstract
Win AK, Hopper JL, Buchanan DD, Young JP, Tenesa A, Dowty JG, Giles GG, Goldblatt J, Winship I, Boussioutas A et al..  2013.  Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? European journal of cancer (Oxford, England : 1990). 49(7):1578-87. Abstract
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M et al..  2015.  Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(8):1229-38. Abstract
Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K et al..  2015.  Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.. JAMA. 313(11):1133-42. Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP et al..  2009.  The association of tumor microsatellite instability phenotype with family history of colorectal cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(3):967-75. Abstract
Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L et al..  2011.  Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers.. Obstetrics and gynecology. 117(4):899-905. Abstract
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S et al..  2013.  Cancer Risks for MLH1 and MSH2 Mutation Carriers.. Human mutation. 34(3):490-7. Abstract
Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC et al..  2010.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.. International journal of cancer. Journal international du cancer. Abstract
Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD et al..  2010.  Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status.. Journal of the National Cancer Institute. 102(6):391-400. Abstract
Heath JA, Reece JC, Buchanan DD, Casey G, Durno CA, Gallinger S, Haile RW, Newcomb PA, Potter JD, Thibodeau SN et al..  2015.  Childhood cancers in families with and without Lynch syndrome.. Familial cancer. 14(4):545-551. Abstract
Shang J, Reece JC, Buchanan DD, Giles GG, Figueiredo JC, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Newcomb PA et al..  2016.  Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status.. International journal of colorectal disease. 31(8):1451-7. Abstract
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM et al..  2008.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.. Gastroenterology. 135(2):419-28. Abstract
Levine JA, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen S, Lindor NM, Newcomb PA, Rosty C, Haile RW et al..  2015.  Clinicopathological risk factor distributions for MLH1 promoter region methylation in CIMP positive tumors.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Phipps AI, Lindor NM, Jenkins MA, Baron JA, Win AK, Gallinger S, Gryfe R, Newcomb PA.  2013.  Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry.. Diseases of the colon and rectum. 56(8):937-44. Abstract
Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I et al..  2012.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(9):958-64. Abstract
Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Diergaarde B, Haile RW, Le Marchand L, Krontiris TG, Younghusband BH et al..  2012.  Colorectal Cancer Linkage on Chromosomes 4q21, 8q13, 12q24, and 15q22.. PloS one. 7(5):e38175. Abstract
Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM et al..  2016.  Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.. Journal of the National Cancer Institute. 108(2) Abstract
Kastrinos F, Steyerberg EW, Balmaña J, Mercado R, Gallinger S, Haile R, Casey G, Hopper JL, Le Marchand L, Lindor NM et al..  2013.  Comparison of the clinical prediction model PREMM1,2,6 and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.. Gut. 62(2):272-279. Abstract
Garcia-Albeniz X, Rudolph A, Hutter C, White E, Lin Y, Rosse SA, Figueiredo JC, Harrison TA, Jiao S, Brenner H et al..  2016.  CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.. British journal of cancer. 114(2):221-9. Abstract
Whiffin N, Dobbins SE, Hosking FJ, Palles C, Tenesa A, Wang Y, Farrington SM, Jones AM, Broderick P, Campbell H et al..  2013.  Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer.. Human molecular genetics. 22(24):5075-82. Abstract
Chau R, Jenkins MA, Buchanan DD, Ouakrim DA, Giles GG, Casey G, Gallinger S, Haile RW, Le Marchand L, Newcomb PA et al..  2016.  Determining the familial risk distribution of colorectal cancer: a data mining approach.. Familial cancer. 15(2):241-251. Abstract
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK et al..  2018.  Discovery of common and rare genetic risk variants for colorectal cancer.. Nature genetics. Abstract